9th Annual Biomarkers Congress

Cancer Biology: Dana-Faber Cancer Institute

Total Score People Score Events Score
42 22 32
Date Event Presentation Speakers
February 17, 2014 Sao Paulo Advanced School in Oncogenesis and Translational Medicine (ESPCA) + Bioinformatics (Mini-course) Molecular-based classification of glioblastoma – Prof. Dr. Cameron Brennan Cameron W Brennan
October 6, 2013 Cell Symposia: Cancer Epigenomics Session 1: Cancer genomics, epigenomics, and epigenetic drivers Lynda Chin
April 6, 2013 AACR Annual Meetings Developmental and Molecular Origins of Brain Tumors Co-Chairpersons: Suzanne J. Baker, St. Jude Children's Research Hospital, Memphis, TN, and Cameron W. Brennan, Memorial Sloan-Kettering Cancer Center, New York, NY Cameron W Brennan
Cancer in the Adolescent and Young Adult Population George D. Demetri
The Next Frontier in Targeted Therapy for Melanoma Chairperson to be announced Lynda Chin
Targeting Cancer Transcription Kimberly Stegmaier, Dana-Farber Cancer Institute, Boston, MA Kimberly Stegmaier
January 20, 2013 Tumor Invasion and Metastasis GEM models in translational research Lynda Chin
December 8, 2012 54th American Society of Haematology Annual Meeting and Exposition New Insights Into the Biology and Treatment of Waldenström Macroglobulinemia Steven P. Treon
December 4, 2012 CTRC-AACR San Antonio Breast Cancer Symposium Tumor Dormancy and Late Recurrences - Ballroom A Nancy U. Lin
November 12, 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Concurrent Session 7 | Title to be announced Lynda Chin
Concurrent Session 7 | Challenges in Genomic-based Characterization of Tumors Lynda Chin
October 20, 2011 Nature Chemical Biology Symposium 2011: Cancer Chemical Biology Welcome and Opening Remarks Kimberly Stegmaier
A chemical genomic approach to modulating mutant notchi Kimberly Stegmaier
Closing Remarks Kimberly Stegmaier
June 20, 2011 Changing Landscape of the Cancer Genome (F3) GBM Lynda Chin
June 20, 2011 Cancer Proteomics 2011 - Systems Biology, Developmental Models and Data Integration A combined chemical genetic/RNAi approach to study cell signalling Ulrike Eggert
February 17, 2011 15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma Update from the 6th International Workshop on the Biology and Therapy of Waldenstrom's Macroglobulinemia Steven P. Treon
December 8, 2010 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium DNA Repair | Ballroom C-3 Daniel P. Silver
Systemic therapy for CNS metastases Nancy U. Lin
CNS Metastases in Breast Cancer: Current Challenges and Future | Ballroom C-1 Nancy U. Lin
DNA repair and breast cancer: Therapeutic opportunities and challenges Daniel P. Silver
Panel Discussion Judy E Garber
November 7, 2010 Ninth Annual International Conference on Frontiers in Cancer Prevention Research PARP inhibitors: Early promise in breast and ovarian cancer prevention Judy E Garber
October 27, 2010 Colorectal Cancer: Biology to Therapy Title to be announced Charles S. Fuchs
September 30, 2010 Third AACR Conference on The Science of Cancer Health Disparities Clinical trials, personalized medicine, and vulnerable patient populations Christopher Lathan
September 30, 2010 Third AACR Conference on the Science of Cancer Health Disparities in Racial / Ethnic Minorities and the Medically Underserved Clinical trials, personalized medicine, and vulnerable patient populations Christopher Lathan
Title to be announced Deborah Schrag
July 20, 2010 Emerging Therapies for Head and Neck Cancer Novel therapeutics for patients with head and neck cancer Robert I. Haddad
Integrating EGFR inhibitors into the curative treatment of head neck cancer Robert I. Haddad
Should the role of induction therapy be revisited? Robert I. Haddad
Welcome and pre-activity assessment Robert I. Haddad
July 11, 2010 Translational Cancer Medicine 2010 (USA) Understanding and managing early-stage cancers Ronald A. DePinho
Functionalizing the cancer genome Lynda Chin
Genomic approaches to drug discovery Kimberly Stegmaier
May 19, 2010 Towards Personalized Cancer Medicine Functionalizing the Cancer Genome Lynda Chin
SESSION III: Oncogenomics and Tumor Profiling Lynda Chin
PANEL DISCUSSION Lynda Chin
November 12, 2009 Sixth International Conference - Revitalizing Cancer Care: Comprehensive Interdisciplinary Programs and Whole Systems Research 1) Preferred Abstracts (6) Elizabeth Dean-Clower
September 19, 2009 Nature Chemical Biology Symposium 2009: Chemical Biology in Drug Discovery A combined chemical genetic/RNAi approach: New tools to study cell division Ulrike Eggert
Targeting cancer pathways with small molecule kinase inhibitors Nathanael Gray
August 5, 2009 New Frontiers in Cancer Drug Development The Lin28 Oncogene and Pluripotency Factor is a Potential Target in Cancer Stem Cells Hao Zhu
February 7, 2009 Translation of the Cancer Genome SESSION 1: CHALLENGES AND OPPORTUNITIES Lynda Chin
November 4, 2008 The Chemotherapy Foundation Symposium XXVI OR Chemotherapy Foundation Symposium, Innovative Cancer Therapy for Tomorrow ADVANCES IN TREATMENT STRATEGIES IN PEDIATRIC ALL Stephen E. , Sallan
September 5, 2008 44th ASCO Annual Meeting General Session I: Risk, Screening, and Prevention Judy E Garber
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
breast cancer-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
cancer genetics-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
cancer genetics-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
cancer prevention/epidemiology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
cancer prevention/epidemiology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
clinical problems in oncology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
clinical problems in oncology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
March 4, 2008 Maintenance of Genome Stability Conference 2008 Session 5: DNA repair and genome stability (Chair: Jiri Lukas) Alan D Andrea
February 3, 2008 AACR - Cytoskeletal Signaling in Cancer SESSION 2: MITOSIS AND CANCER David Steven Pellman
December 1, 2007 47TH American Socieity of Cell Biology Yeast Formins Bni1 and Bnr1 Utilize Different Modes of Cortical Interaction during the Assembly of Actin Cables David Steven Pellman
Amaxa GmbH: Alan D Andrea
October 16, 2007 Fifth Annual RNAi for Drug Discovery and Therapeutics - Best Practices from the Bench to the Clinic Oct (16-17) RNAi Targets and Cancer Biology (10:40-12:55) So Young Kim
RNAi Targets and Cancer Biology: Integration of Functional Genomic Approaches to Uncover Novel Cancer Genes (11:10-11:40) So Young Kim
September 7, 2007 The 2007 Breast Symposium The Impact of Local Treatment on Long-Term Survival: Local Control Matters Jay R Harris, MD
July 21, 2007 Hematopoietic Malignancies The Fanconi Anemia/BRCA pathway and the DNA damage response Alan D Andrea
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.